Markers of cognitive resilience and a framework for investigating clinical heterogeneity in ALS<sup></sup>.

Mehta, Puja R; Lashley, Tammaryn; Fratta, Pietro; Bampton, Alexander

Markers of cognitive resilience and a framework for investigating clinical heterogeneity in ALS.

Mehta, Puja R; Lashley, Tammaryn; Fratta, Pietro; Bampton, Alexander.

Afiliación

Mehta PR; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Lashley T; Department of Clinical and Movement Neuroscience, The Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
Fratta P; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Bampton A; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.

J Pathol ; 257(3): 251-254, 2022 07.

Article en En | MEDLINE | ID: mdl-35342958

Asunto(s)

Esclerosis Amiotrófica Lateral; Enfermedades Neurodegenerativas; Esclerosis Amiotrófica Lateral/patología; Biomarcadores; Cognición; Humanos; Inflamasomas/metabolismo; Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo

Palabras clave

IL-1; IL-6; NLRP3; SIRT2; amyotrophic lateral sclerosis; cognition; inflammasome; motor neuron disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Esclerosis Amiotrófica Lateral Límite: Humans Idioma: En Revista: J Pathol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google